Inhibitory synapses control decorrelation between <i>U</i>_<i>e</i> and mean noisy input. by Scott Rich (9873638)

“…<p><b>A–D</b>: Plots of the Pearson correlation coefficient between <i>U</i>_<i>e</i> (during baseline activity) and the mean (over all neurons during baseline activity) noisy input to the microcircuit as a function of the input correlation <i>c</i> (x-axis) and synaptic strengths (color coding). …”

Mean baseline BOLD responses to whisker stimulation and their changes at 2 and 5 weeks after the stepwise BCCAo in the saline-treated group. by Gabriella Nyitrai (370339)

“…Contrast images show decreased BOLD response 2 weeks after (2 weeks difference from mean baseline; middle row, n = 12) and restored BOLD response at 5 weeks (5 weeks difference from mean baseline; bottom row, n = 12) after the stepwise carotid occlusion. …”

Data Sheet 1_Lack of association between genetic variations in CYP3A5 and blood pressure or hypertension risk in the UK biobank.pdf by Pia Leibold (21390134)

“…While some previous studies reported that CYP3A5 variants were associated with decreased blood pressure and risk of HTN, others reported no associations. …”

Mean PCC increased for 10 of 11 test GSC datasets when H3K27Ac is the only feature. by Yusuke Suita (14381481)

Binding analysis of representative water-soluble vitamins to T1r2a/T1r3LBD. by Hikaru Ishida (18239420)

Percentage of strong-positively stained sperm for GABA A-α1 receptor immunostaining (METH vs. control). by Paweena Kaewman (14329011)

Downregulation of Opa1 and Marf does affect type II NB numbers but affect differentiated cells in lineage. by Dnyanesh Dubal (12085942)

Drp1^SD overexpression partially alleviates the differentiation defect seen in <i>notch</i> RNAi expressing type II NB lineages. by Dnyanesh Dubal (12085942)

Drp1^SD overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential. by Dnyanesh Dubal (12085942)

“…<p>A, B: Representative images showing decreased TMRM intensity in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NBs. …”

Mean baseline BOLD responses to whisker stimulation and their changes at 2 and 5 weeks after the stepwise BCCAo in the donepezil-treated group. by Gabriella Nyitrai (370339)

“…<p>The mean activation evoked by the whisker sensory stimulation in the donepezil-treated group before the stepwise carotid occlusion (upper row, n = 14). …”

Summary plots of P300 peak amplitude and latency means for averaged ERPs: larger and faster responses for most salient stimuli. by Marta Teixeira (514064)

“…<p>Top: A, B, C, E - mean peak amplitudes for A. Color/Luminance (exp I); B. …”

Mean biomass (g per ha ± s.e.) of fish species in three station groups identified from MDS classification. by David R. Currie (188413)

Expression of mRFP does not perturb the severity of <i>opa1</i> RNAi and <i>marf</i> RNAi phenotypes. by Dnyanesh Dubal (12085942)

Influences of parabolic flight on activity and heart rate. by Peiliang Wang (753153)

Binding analysis of typical CaSR ligands to T1r2a/T1r3LBD. by Hikaru Ishida (18239420)

Analysis of change in mature INPs, GMCs and neurons in the type II NB lineage on depletion of mitochondrial morphology proteins. by Dnyanesh Dubal (12085942)

Mean histopathological severity scores in control, paraquat and MPTP-treated groups of C57BL/6J male mice. by Richard Jay Smeyne (3278886)

“…Serial sections through the SNpc were evaluated qualitatively and the group mean severity grades are plotted. Grades 0 to 5 reflect increasing intensity of staining for Iba-1, AmCuGg, GFAP and decreased staining intensity of TH.…”

Mean ReHo maps within the MNE, non-NE and healthy control groups (P<0.01, FDR corrected). by Xue Liang (449130)

“…<p>The PCC/precuneus, MPFC, IPL, bilateral middle/inferior temporal gyrus, cuneus and thalamus exhibit significantly higher ReHo values than the global mean ReHo value within each group, and with a gradually decreasing tendency from normal controls, non-NE to MNE. …”

Binding analysis of typical ligands for T1rs to T1r2a/T1r3LBD. by Hikaru Ishida (18239420)

2-DG blocks HHV-6-mediated glycolytic activation. by Zhisheng Wu (1540864)

“…<b>(A)</b> 2-DG treatment significantly decreased glucose uptake in HHV-6-infected cells. …”